Tablets 250 mg
- Endocrine therapy. Other hormone antagonists and related agents.
- Abiraterone acetate is converted in vivo to abiraterone. Abiraterone selectively inhibits the enzyme 7α-hydroxylase/C17,20-lyase (CYP17) required for androgen biosynthesis in testicular, adrenal and prostatic tumor tissues.
- ABIRATERONE ACETATE is indicated in combination with prednisone or prednisolone for the treatment of patients with metastatic castration-resistant prostate cancer as well as metastatic castration-sensitive prostate cancer.
- Abiraterone acetate is prescribed for daily use for as long as the drug continues to be effective and tolerated.